Aarskog-Scott syndrome
Last updated 27 May 2022
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Aarskog-Scott syndrome is a genetic disorder that affects the development of many parts of the body, most commonly the head and face, the hands and feet, and the genitals and urinary system (genitourinary tract). This condition mainly affects males, although females may have mild features of the syndrome.
Video picks for Genetic conditionsVideo library
Description
Aarskog-Scott syndrome is a genetic disorder that affects the development of many parts of the body, most commonly the head and face, the hands and feet, and the genitals and urinary system (genitourinary tract). This condition mainly affects males, although females may have mild features of the syndrome.
People with Aarskog-Scott syndrome often have distinctive facial features, such as widely spaced eyes (hypertelorism), a small nose, a long area between the nose and mouth (philtrum), and a widow's peak hairline. They frequently have mild to moderate short stature during childhood, but their growth usually catches up with that of their peers during puberty. Hand abnormalities are common in this syndrome and include short fingers (brachydactyly), curved pinky fingers (fifth finger clinodactyly), webbing of the skin between some fingers (cutaneous syndactyly), and a single crease across the palm. Affected individuals can also have wide, flat feet with broad, rounded toes. Other abnormalities in people with Aarskog-Scott syndrome include heart defects and a split in the upper lip (cleft lip) with or without an opening in the roof of the mouth (cleft palate).
Most males with Aarskog-Scott syndrome have a shawl scrotum, in which the scrotum surrounds the penis instead of hanging below. Less often, they have undescended testes (cryptorchidism) or a soft out-pouching around the belly-button (umbilical hernia) or in the lower abdomen (inguinal hernia).
The intellectual development of people with Aarskog-Scott syndrome varies widely. Most individuals with Aarskog-Scott syndrome have normal intelligence; however, some may have mild learning and behaviour problems, and in rare cases, severe intellectual disability has been reported.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant; X-linked recessive; Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Aarskog syndrome
AAS
Facio-digito-genital dysplasia
Faciodigitogenital syndrome
Faciogenital dysplasia
FGDY
Patient picks for Genetic conditions

Brain and nerves
Cervical rib
About 1 in 100 people are born with an extra rib called a cervical rib. About 1 in 10 people who have a cervical rib develop thoracic outlet syndrome. This happens if the cervical rib squashes the nerves and blood vessels going into the arm. Treatment can include painkillers, physiotherapy and sometimes surgery to relieve the compression caused by, for example, a cervical rib.
by Dr Doug McKechnie, MRCGP

Bones, joints and muscles
What is hypermobility syndrome?
Having supple joints with a wide range of motion allows the body to move freely, and for some people - gymnasts, athletes and dancers, for example - this can be an advantage. But being super flexible can have its drawbacks, too. When you're hypermobile, your joints move easily beyond the normal range. Over time, this can cause pain and in the very worst cases, dislocation or long-term damage to the joint. It can also be linked to a range of issues in other parts of the body.
by Allie Anderson

Kidney and urinary tract
Nephrotic syndrome
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. The main symptom is fluid retention (oedema) which is mainly due to the low protein level in the blood. Various diseases can cause nephrotic syndrome, some more serious than others. Treatment and outcome (prognosis) vary, depending on the cause. The most common cause in children, minimal change disease, usually responds very well to treatment.
by Dr Surangi Mendis, MRCGP

Bones, joints and muscles
Hypermobility spectrum disorders
Hypermobility spectrum disorders include all people with what used to be called joint hypermobility syndrome, and before that benign joint hypermobility syndrome. Anyone who has symptoms as a result of having hypermobile joints, but who does not have all the features of Ehlers-Danlos syndrome, has a hypermobility spectrum disorder. These problems mainly affect children and young adolescents with extra-flexible (hypermobile) joints who develop pain on exercise, which persists when they rest. These conditions can have a major impact on school and sporting life. Whilst they do not usually cause long-term harm, they can be associated with injuries and can sometimes persist into adulthood. Treatment is aimed at increasing muscle strength and joint resilience without causing injury.
by Dr Colin Tidy, MRCGP

Children's health
Cot death
The cause of cot death is not known. However, you can reduce the risk of cot death by the measures detailed below. The most important are to lay your baby on his or her back to sleep (not on their front or side) and to create a smoke-free zone for your baby.
by Dr Toni Hazell, FRCGP

Heart health and blood vessels
Microvascular angina
There is no agreed definition for CSX. The underlying cause may be sudden narrowing (spasm) of normal coronary arteries without any evidence of atheromatous fatty plaques.
by Dr Hayley Willacy, FRCGP
Related patient information and medicines

Patient information leaflet
Pre-eclampsia
...info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest: [https://uk.pinterest.com/patient/](https://uk.pinterest.com/patient/) Instagram: [https://www.instagram.com/patient.info/](https://www.instagram.com/patient.info/) Pre-eclampsia.

Patient information leaflet
Cervical rib
About 1 in 100 people are born with an extra rib called a cervical rib. About 1 in 10 people who have a cervical rib develop thoracic outlet syndrome. Treatment can include painkillers, physiotherapy and sometimes surgery to relieve the compression caused by, for example, a cervical rib. ServiceUpsellPlaceholder What is a cervical rib. About 1 in.

Patient information leaflet
Nephrotic syndrome
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. Various diseases can cause nephrotic syndrome, some more serious than others. What is nephrotic syndrome. Nephrotic syndrome is not a single disease - it is a syndrome. A syndrome is a set of symptoms.

Patient information leaflet
Hypermobility spectrum disorders
Hypermobility spectrum disorders include all people with what used to be called joint hypermobility syndrome, and before that benign joint hypermobility syndrome. Anyone who has symptoms as a result of having hypermobile joints, but who does not have all the features of Ehlers-Danlos syndrome, has a hypermobility spectrum disorder. These problems.
Patient information leaflet
Fetal anticonvulsant syndrome
Fetal anticonvulsant syndrome (FACS) - also known as fetal valproate syndrome and fetal hydantoin syndrome - is a group of malformations that can affect some babies if they are exposed to certain medicines known as antiepileptic drugs (AEDs) while in the womb. Most women with epilepsy will have a healthy child. Women with epilepsy who are pregnant.

Patient information leaflet
Cot death
However, you can reduce the risk of cot death by the measures detailed below. The most important are to lay your baby on his or her back to sleep (not on their front or side) and to create a smoke-free zone for your baby. What is cot death. Cot death is more properly known as sudden infant death syndrome (SIDS). It is the term used to describe the.
Further reading and references
- Aarskog-Scott syndrome; MedlinePlus, National Library of Medicine.
- Daubon T, Buccione R, Genot E. The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor beta-stimulated aortic endothelial cells. Mol Cell Biol. 2011 Nov;31(22):4430-41. doi: 10.1128/MCB.05474-11. Epub 2011 Sep 12.
- Estrada L, Caron E, Gorski JL. Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane. Hum Mol Genet. 2001 Mar 1;10(5):485-95. doi: 10.1093/hmg/10.5.485.
- Gao L, Gorski JL, Chen CS. The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells. Am J Pathol. 2011 Mar;178(3):969-74. doi: 10.1016/j.ajpath.2010.11.051.
- Genot E, Daubon T, Sorrentino V, Buccione R. FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia. J Cell Sci. 2012 Jul 15;125(Pt 14):3265-70. doi: 10.1242/jcs.093419. Epub 2012 Aug 1.
- Hou P, Estrada L, Kinley AW, Parsons JT, Vojtek AB, Gorski JL. Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum Mol Genet. 2003 Aug 15;12(16):1981-93. doi: 10.1093/hmg/ddg209.
- Orrico A, Galli L, Buoni S, Hayek G, Luchetti A, Lorenzini S, Zappella M, Pomponi MG, Sorrentino V. Attention-deficit/hyperactivity disorder (ADHD) and variable clinical expression of Aarskog-Scott syndrome due to a novel FGD1 gene mutation (R408Q). Am J Med Genet A. 2005 May 15;135(1):99-102. doi: 10.1002/ajmg.a.30700.
- Orrico A, Galli L, Cavaliere ML, Garavelli L, Fryns JP, Crushell E, Rinaldi MM, Medeira A, Sorrentino V. Phenotypic and molecular characterisation of the Aarskog-Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patients. Eur J Hum Genet. 2004 Jan;12(1):16-23. doi: 10.1038/sj.ejhg.5201081.
- Orrico A, Galli L, Faivre L, Clayton-Smith J, Azzarello-Burri SM, Hertz JM, Jacquemont S, Taurisano R, Arroyo Carrera I, Tarantino E, Devriendt K, Melis D, Thelle T, Meinhardt U, Sorrentino V. Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. Am J Med Genet A. 2010 Feb;152A(2):313-8. doi: 10.1002/ajmg.a.33199.
- Oshima T, Fujino T, Ando K, Hayakawa M. Role of FGD1, a Cdc42 guanine nucleotide exchange factor, in epidermal growth factor-stimulated c-Jun NH2-terminal kinase activation and cell migration. Biol Pharm Bull. 2011;34(1):54-60. doi: 10.1248/bpb.34.54.
- Zanetti Drumond V, Sousa Salgado L, Sousa Salgado C, Oliveira VAL, de Assis EM, Campos Ribeiro M, Furtado Valadao A, Orrico A. The Prevalence of Clinical Features in Patients with Aarskog-Scott Syndrome and Assessment of Genotype-Phenotype Correlation: A Systematic Review. Genet Res (Camb). 2021 Feb 2;2021:6652957. doi: 10.1155/2021/6652957. eCollection 2021.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

